BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11914585)

  • 41. Artificial nine zinc-finger peptide with 30 base pair binding sites.
    Kamiuchi T; Abe E; Imanishi M; Kaji T; Nagaoka M; Sugiura Y
    Biochemistry; 1998 Sep; 37(39):13827-34. PubMed ID: 9753472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional domains of Moloney murine leukemia virus integrase defined by mutation and complementation analysis.
    Jonsson CB; Donzella GA; Gaucan E; Smith CM; Roth MJ
    J Virol; 1996 Jul; 70(7):4585-97. PubMed ID: 8676485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.
    Gunther M; Laithier M; Brison O
    Mol Cell Biochem; 2000 Jul; 210(1-2):131-42. PubMed ID: 10976766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of the in vitro integration of Moloney murine leukemia virus DNA by the DNA minor groove binder netropsin.
    Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
    Biochem Pharmacol; 1994 May; 47(10):1821-6. PubMed ID: 8204098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification of Moloney murine leukemia virus chromatin from infected cells by an affinity method.
    Granger SW; Fan H
    J Biomed Sci; 2001; 8(3):278-89. PubMed ID: 11385300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C-terminal in Sp1-like artificial zinc-finger proteins plays crucial roles in determining their DNA binding affinity.
    Zhang B; Xiang S; Yin Y; Gu L; Deng D
    BMC Biotechnol; 2013 Dec; 13():106. PubMed ID: 24289163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The integrated genome of murine leukemia virus.
    Steffen D; Weinberg RA
    Cell; 1978 Nov; 15(3):1003-10. PubMed ID: 728982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z; Maher VM; McCormick JJ
    Gene; 2005 May; 351():51-9. PubMed ID: 15857802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation and analysis of retroviral integration targets by solo long terminal repeat inverse PCR.
    Jin YF; Ishibashi T; Nomoto A; Masuda M
    J Virol; 2002 Jun; 76(11):5540-7. PubMed ID: 11991982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correct integration mediated by integrase-LexA fusion proteins incorporated into HIV-1.
    Holmes-Son ML; Chow SA
    Mol Ther; 2002 Apr; 5(4):360-70. PubMed ID: 11945062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cells.
    Tan W; Dong Z; Wilkinson TA; Barbas CF; Chow SA
    J Virol; 2006 Feb; 80(4):1939-48. PubMed ID: 16439549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Forced integration of Moloney murine leukemia virus DNA with a mutant integration site occurs through recombination with VL30 DNA.
    Murphy JE; Goff SP
    Virology; 1994 Oct; 204(1):458-61. PubMed ID: 8091679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of substrate structure on disintegration activity of Moloney murine leukemia virus integrase.
    Donzella GA; Jonsson CB; Roth MJ
    J Virol; 1993 Dec; 67(12):7077-87. PubMed ID: 8230431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Moloney murine leukemia virus IN protein from disrupted virions binds and specifically cleaves its target sequence in vitro.
    Ishimoto LK; Halperin M; Champoux JJ
    Virology; 1991 Feb; 180(2):527-34. PubMed ID: 1989383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection.
    Seamon JA; Jones KS; Miller C; Roth MJ
    J Virol; 2002 Aug; 76(16):8475-84. PubMed ID: 12134052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus.
    Flanagan JR; Becker KG; Ennist DL; Gleason SL; Driggers PH; Levi BZ; Appella E; Ozato K
    Mol Cell Biol; 1992 Jan; 12(1):38-44. PubMed ID: 1309593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amino acid substitutions in the SP1 zinc finger domain alter the DNA binding affinity to cognate SP1 target site.
    Thiesen HJ; Schröder B
    Biochem Biophys Res Commun; 1991 Feb; 175(1):333-8. PubMed ID: 1998516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feline leukemia virus integrase and capsid packaging functions do not change the insertion profile of standard Moloney retroviral vectors.
    Métais JY; Topp S; Doty RT; Borate B; Nguyen AD; Wolfsberg TG; Abkowitz JL; Dunbar CE
    Gene Ther; 2010 Jun; 17(6):799-804. PubMed ID: 20237508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat.
    Faller DV; Weng H; Choi SY
    Virology; 1997 Jan; 227(2):331-42. PubMed ID: 9018132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo.
    Murphy JE; Goff SP
    J Virol; 1992 Aug; 66(8):5092-5. PubMed ID: 1629963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.